Avrobio Inc reported $175.34M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Akebia Therapeutics AKBA:US $ 535.36M 9.81M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Applied Genetic Technologies AGTC:US $ 87.19M 5.18M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Epizyme EPZM:US $ 312.19M 23.19M
Gilead Sciences GILD:US $ 63080M 4872M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
IONIS PHARMACEUT IONS:US $ 2519.09M 92.6M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Sangamo Biosciences SGMO:US $ 654.31M 67.61M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Takeda 4502:JP Y 13178018M 479499M